Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment

Abstract

PurposeThere are few reports from Asian countries about the long-term results of aromatase inhibitor adjuvant treatment for breast cancer. This observational study aimed to evaluate the long-term effects of letrozole in postmenopausal Korean women with operable breast cancer.MethodsSelf-reported quality of life (QoL) scores were serially assessed for 3 years during adjuvant letrozole treatment using the Korean version of the Functional Assessment of Cancer Therapy-Breast questionnaires (version 3). Changes in bone mineral density (BMD) and serum cholesterol levels were also examined.ResultsAll 897 patients received the documented informed consent form and completed a baseline questionnaire before treatment. Adjuvant chemotherapy was administered to 684 (76.3%) subjects, and 410 (45.7%) and 396 (44.1%) patients had stage I and II breast cancer, respectively. Each patient completed questionnaires at 3, 6, 12, 18, 24, 30, and 36 months after enrollment. Of 897 patients, 749 (83.5%) completed the study. The dropout rate was 16.5%. The serial trial outcome index, the sum of the physical and functional well-being subscales, increased gradually and significantly from baseline during letrozole treatment (p<0.001). The mean serum cholesterol level increased significantly from 199 to 205 after 36 months (p=0.042). The mean BMD significantly decreased from −0.39 at baseline to −0.87 after 36 months (p<0.001).ConclusionQoL gradually improved during letrozole treatment. BMD and serum cholesterol level changes were similar to those in Western countries, indicating that adjuvant letrozole treatment is well tolerated in Korean women, with minimal ethnic variation.

Synergistic Effect of Perovskites and Nitrogen-Doped Carbon Hybrid Materials for Improving Oxygen Reduction Reaction

“…BSCF has a moderate surface oxygen interaction energy, which causes it to be neither weak nor strong in the adsorption of O 2 ; thus, it is located at the top of the volcano plot with the σ * -orbital (e. g . lling) value ≈ 1.2 [20]. Pseudocubic PBCO, comprising rich oxygen vacancies concentrated in the Pr plane, forms because of the considerable difference in the ionic radius and polarizability between praseodymium and barium atoms [10].…”

Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer

“…The incidence and mortality of BC malignant tumor are increasing year by year. The TNBC tumor type has a poor prognosis, difficult treatment, poor long-term efficacy, which negatively impacts the quality of life of patients (30,31). This study investigated the effect of apatinib which selectively acts on VEGFR-2 apoptosis of TNBC based on the PI3K/p65/Bcl-xl molecular pathway.…”

Acupoint Thread Embedding Combined With Wenshen Bugu Decoction for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptom Among Postmenopausal Breast Cancer Patients: Study Protocol of a Randomized Controlled Trial

“… 1 , 2 Early-stage breast cancer accounts for more than 80% of all breast cancer, and 68% of breast cancer diagnoses are hormone receptor-positive (HR+), with approximately two-thirds being postmenopausal women. 3 , 4 For decades, 5 year tamoxifen has been regarded as the gold standard for adjuvant endocrine therapy for early breast cancer. 5 Compared with tamoxifen, the third-generation aromatase inhibitors (AIs) have been shown to significantly improve disease-free survival (DFS) and reduce the risk of recurrence of contralateral breast cancer among postmenopausal women with HR+ breast cancer.…”